AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Snipd AI
Alex Colville, co-founder of Age1, talks about funding longevity science, studying the biology of ageing, the rise of geroscience, healthspan, the potential of metformin, working on an anti-ageing treatment, and how long he thinks we'll live.
Read more
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- The field of aging research is shifting towards treating aging as an affliction that can be treated, rather than solely focusing on age-related diseases.
- Geroprotectors, interventions that target the biological processes of aging, have the potential to significantly extend human lifespan and healthspan if further research and trials are conducted.
Deep dives
Investing in Longevity
Alex Colville, co-founder of the investment fund H1, discusses their mission to invest in startups focused on extending healthy life through aging interventions. They aim to support entrepreneurs in developing the 'magic pill' that can significantly extend human lifespan. With increasing attention and funding in the field, they believe that groundbreaking therapies for aging could be approved within the next decade.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode